Salivary inflammatory biomarkers are predictive of mild cognitive impairment and Alzheimer’s disease in a feasibility study

Alzheimer’s disease (AD) is an insidious disease. Its distinctive pathology forms over a considerable length of time without symptoms. There is a need to detect this disease, before even subtle changes occur in cognition. Hallmark AD biomarkers, tau and amyloid-β, have shown promising results in CSF...

Descripción completa

Detalles Bibliográficos
Autores principales: McNicholas, Kym, François, Maxime, Liu, Jian-Wei, Doecke, James D., Hecker, Jane, Faunt, Jeff, Maddison, John, Johns, Sally, Pukala, Tara L., Rush, Robert A., Leifert, Wayne R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Aging Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685799/
https://www.ncbi.nlm.nih.gov/pubmed/36438010
http://dx.doi.org/10.3389/fnagi.2022.1019296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685799/
https://www.ncbi.nlm.nih.gov/pubmed/36438010
http://dx.doi.org/10.3389/fnagi.2022.1019296

Ejemplares similares